Global Human Injection Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 111
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Human Injection Flu Vaccine market size was valued at USD 7856 million in 2023 and is forecast to a readjusted size of USD 11110 million by 2030 with a CAGR of 5.1% during review period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Human Injection Flu Vaccine industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Injection Flu Vaccine.
Regionally, the report analyzes the Human Injection Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Injection Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Human Injection Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Injection Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Injection Flu Vaccine market.
Regional Analysis: The report involves examining the Human Injection Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Injection Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Human Injection Flu Vaccine:
Company Analysis: Report covers individual Human Injection Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Injection Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Human Injection Flu Vaccine. It assesses the current state, advancements, and potential future developments in Human Injection Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Injection Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Human Injection Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Injection Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Injection Flu Vaccine, with price, sales, revenue and global market share of Human Injection Flu Vaccine from 2019 to 2024.
Chapter 3, the Human Injection Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Injection Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Injection Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Injection Flu Vaccine.
Chapter 14 and 15, to describe Human Injection Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Human Injection Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Injection Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Human Injection Flu Vaccine Market Size & Forecast
1.5.1 Global Human Injection Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Human Injection Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Human Injection Flu Vaccine Average Price (2019-2030)
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Human Injection Flu Vaccine Product and Services
2.1.4 Sanofi Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Human Injection Flu Vaccine Product and Services
2.2.4 CSL Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Human Injection Flu Vaccine Product and Services
2.3.4 GSK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Human Injection Flu Vaccine Product and Services
2.4.4 Viatris Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Viatris Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Human Injection Flu Vaccine Product and Services
2.5.4 AstraZeneca Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business
2.6.3 Hualan Bio Human Injection Flu Vaccine Product and Services
2.6.4 Hualan Bio Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hualan Bio Recent Developments/Updates
2.7 Changchun Institute of Biological
2.7.1 Changchun Institute of Biological Details
2.7.2 Changchun Institute of Biological Major Business
2.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
2.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Changchun Institute of Biological Recent Developments/Updates
2.8 Sinovac
2.8.1 Sinovac Details
2.8.2 Sinovac Major Business
2.8.3 Sinovac Human Injection Flu Vaccine Product and Services
2.8.4 Sinovac Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Recent Developments/Updates
2.9 Jiangsu GDK
2.9.1 Jiangsu GDK Details
2.9.2 Jiangsu GDK Major Business
2.9.3 Jiangsu GDK Human Injection Flu Vaccine Product and Services
2.9.4 Jiangsu GDK Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Jiangsu GDK Recent Developments/Updates
2.10 KM Biologics
2.10.1 KM Biologics Details
2.10.2 KM Biologics Major Business
2.10.3 KM Biologics Human Injection Flu Vaccine Product and Services
2.10.4 KM Biologics Human Injection Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 KM Biologics Recent Developments/Updates
3.1 Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Human Injection Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Human Injection Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Human Injection Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Human Injection Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Human Injection Flu Vaccine Manufacturer Market Share in 2023
3.5 Human Injection Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Injection Flu Vaccine Market: Region Footprint
3.5.2 Human Injection Flu Vaccine Market: Company Product Type Footprint
3.5.3 Human Injection Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Human Injection Flu Vaccine Market Size by Region
4.1.1 Global Human Injection Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Human Injection Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Human Injection Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Human Injection Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Human Injection Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Human Injection Flu Vaccine Consumption Value (2019-2030)
4.5 South America Human Injection Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Human Injection Flu Vaccine Consumption Value (2019-2030)
5.1 Global Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Human Injection Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Human Injection Flu Vaccine Average Price by Type (2019-2030)
6.1 Global Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Human Injection Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Human Injection Flu Vaccine Average Price by Application (2019-2030)
7.1 North America Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Human Injection Flu Vaccine Market Size by Country
7.3.1 North America Human Injection Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Human Injection Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Human Injection Flu Vaccine Market Size by Country
8.3.1 Europe Human Injection Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Human Injection Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Human Injection Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Human Injection Flu Vaccine Market Size by Country
10.3.1 South America Human Injection Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Human Injection Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Human Injection Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Human Injection Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Human Injection Flu Vaccine Market Drivers
12.2 Human Injection Flu Vaccine Market Restraints
12.3 Human Injection Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Human Injection Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Injection Flu Vaccine
13.3 Human Injection Flu Vaccine Production Process
13.4 Human Injection Flu Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Injection Flu Vaccine Typical Distributors
14.3 Human Injection Flu Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Human Injection Flu Vaccine Product and Services
Table 6. Sanofi Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Human Injection Flu Vaccine Product and Services
Table 11. CSL Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Human Injection Flu Vaccine Product and Services
Table 16. GSK Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GSK Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Human Injection Flu Vaccine Product and Services
Table 21. Viatris Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Viatris Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Human Injection Flu Vaccine Product and Services
Table 26. AstraZeneca Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 29. Hualan Bio Major Business
Table 30. Hualan Bio Human Injection Flu Vaccine Product and Services
Table 31. Hualan Bio Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Hualan Bio Recent Developments/Updates
Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 34. Changchun Institute of Biological Major Business
Table 35. Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
Table 36. Changchun Institute of Biological Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Changchun Institute of Biological Recent Developments/Updates
Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Major Business
Table 40. Sinovac Human Injection Flu Vaccine Product and Services
Table 41. Sinovac Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sinovac Recent Developments/Updates
Table 43. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu GDK Major Business
Table 45. Jiangsu GDK Human Injection Flu Vaccine Product and Services
Table 46. Jiangsu GDK Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Jiangsu GDK Recent Developments/Updates
Table 48. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 49. KM Biologics Major Business
Table 50. KM Biologics Human Injection Flu Vaccine Product and Services
Table 51. KM Biologics Human Injection Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. KM Biologics Recent Developments/Updates
Table 53. Global Human Injection Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Human Injection Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Human Injection Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Injection Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Human Injection Flu Vaccine Production Site of Key Manufacturer
Table 58. Human Injection Flu Vaccine Market: Company Product Type Footprint
Table 59. Human Injection Flu Vaccine Market: Company Product Application Footprint
Table 60. Human Injection Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Human Injection Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Injection Flu Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Human Injection Flu Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Human Injection Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Human Injection Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Human Injection Flu Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Human Injection Flu Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Human Injection Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Human Injection Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Human Injection Flu Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Human Injection Flu Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Human Injection Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Human Injection Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Human Injection Flu Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Human Injection Flu Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Human Injection Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Human Injection Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Human Injection Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Human Injection Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Human Injection Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Human Injection Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Human Injection Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Human Injection Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Human Injection Flu Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Human Injection Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Human Injection Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Human Injection Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Human Injection Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Human Injection Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Human Injection Flu Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Human Injection Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Human Injection Flu Vaccine Raw Material
Table 121. Key Manufacturers of Human Injection Flu Vaccine Raw Materials
Table 122. Human Injection Flu Vaccine Typical Distributors
Table 123. Human Injection Flu Vaccine Typical Customers
List of Figures
Figure 1. Human Injection Flu Vaccine Picture
Figure 2. Global Human Injection Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Human Injection Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Human Injection Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Human Injection Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 8. 6 Months to 3 Years Examples
Figure 9. > 3 Years Examples
Figure 10. Global Human Injection Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Human Injection Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Human Injection Flu Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Human Injection Flu Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 14. Global Human Injection Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Human Injection Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Human Injection Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Human Injection Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Human Injection Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Human Injection Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Human Injection Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Human Injection Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Human Injection Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Human Injection Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Human Injection Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Human Injection Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Human Injection Flu Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Human Injection Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Human Injection Flu Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Human Injection Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Human Injection Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Human Injection Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Human Injection Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Human Injection Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Human Injection Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Human Injection Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Human Injection Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Human Injection Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Human Injection Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Human Injection Flu Vaccine Market Drivers
Figure 73. Human Injection Flu Vaccine Market Restraints
Figure 74. Human Injection Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Human Injection Flu Vaccine
Figure 78. Human Injection Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi CSL GSK Viatris AstraZeneca Hualan Bio Changchun Institute of Biological Sinovac Jiangsu GDK KM Biologics
Related Reports
06 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
